發送短信 : Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective

 __   __    _____    __   _     ______    ______  
 \ \\/ //  |  ___|| | || | ||  /_   _//  /_____// 
  \   //   | ||__   | '--' ||   -| ||-   `____ `  
  / . \\   | ||__   | .--. ||   _| ||_   /___//   
 /_//\_\\  |_____|| |_|| |_||  /_____//  `__ `    
 `-`  --`  `-----`  `-`  `-`   `-----`   /_//     
                                         `-`